Details of the Drug Reposition

General Information of This Drug (ID: DM5UQA9)

Drug Name
Anti-meso-CAR vector transduced T cells   DM5UQA9
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
5 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Pancreatic cancer DISJC981 2C10 Phase 1 [1]
Malignant mesothelioma DISTHJGH 2C26.0 Phase 1 [1]
Triple negative breast cancer DISAMG6N 2C60-2C65 Phase 1 [1]
Ovarian cancer DISZJHAP 2C73 Phase 1 [1]
Endometrial cancer DISW0LMR 2C76 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02580747) Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso